(0:00 - 2:26) After Donald Trump appointed such persons as Robert Kennedy Jr., Dr. Marty Makary, and Dr. Jay Bhattacharya as heads of Health and Human Services, the FDA, and the National Institutes of Health respectively, as well as a number of others who have been outspoken critics of mRNA vaccines to key positions, there was a great deal of hope that it would not be long before mRNA gene therapies would be banned, at least in the U.S. But nine months after Donald Trump took office, that has not happened. In fact, other than a very recent withdrawal of half a billion dollars for mRNA research, no steps have been taken to curtail the use or availability of these shots. Dr. Robert Malone is well known as the inventor of mRNA gene therapies, a mission which he took on many years ago under the purest of motives, a belief that these technologies could be used to treat genetic disorders.   Dr. Malone also abandoned that research many years ago of his own free will when he discovered that there was no way to safely use that technology. The risks simply far outweighed the potential benefits. Dr. Malone also has decades of experience working with the government of the United States, with various health departments, and with the Department of Defense, and he is currently co-chair of the CDC Advisory Committee on Immunization Practices, after having been originally appointed as an advisor by Robert Kennedy Jr. Throughout his tenure with these government organizations, Robert has also had many interactions with the intelligence community, and so understands on a very deep level how they operate.   He's published two very important books on government corruption and manipulation of the people, Lies My Gov't Told Me, and published last October, PsyWar: Enforcing the New World Order. Dr. Malone joins me today to explain the complex reasons why these dangerous injections are still not only available to the public, but are still being recommended by the various US health agencies. The answers are far from simple, but Dr. Malone remains hopeful that in time, the data which tells the real story will be allowed to dictate policy.   (2:34 - 5:38) Robert, it's a pleasure to have you back on the show. My pleasure as always, and thank you for the opportunity to speak to your viewers and colleagues up there in the People's Republic of Canada. Well put.   Before we get into the things, the specific things that I wanted to talk to you about today, there's a lot of people still who only see you as or know you as the inventor of mRNA. They do not know about your vast experience working with the government, the deep state, probably don't know about your current appointment as an advisor and coacher, I believe on ACIP appointed by Robert Kennedy. So would you please give the viewers a brief summary of that experience that you have? So the challenge in addressing that is the statement brief.   So I'll do my best. The whole mRNA story thing happened when I was 28, and working on my MD-PhD, I ended up with a master's because I had a nervous breakdown over all the downstream effects of having these inventions and the avaricious behavior of various attorneys and other scientists and academics in the context of the Salk Institute in UC San Diego, which are across the street from each other, but competitive and not under the same administrative structure, which means they don't have the same patent royalty structure, which is the key item here, having to do with the Bayh-Dole Act, which was relatively recently implemented. So that's way back in the past.   I was then an academic in pathology at University of California Davis in the Department of Pathology, teaching medical students PATH for a number of years and running basically a discovery non-viral gene therapy laboratory and then was recruited from that to University of Maryland in the Department of Pathology, where I also taught pathology and molecular biology to medical students and graduate PhD students. And then, you know, I left out the small business at VyCal, where a lot of the mRNA tech and DNA vaccine tech was reduced to practice back in about 1990, 1991. So, University of Maryland, Baltimore, and then Uniformed Services, University of Health Sciences, which is the DoD medical school in Bethesda, where I set up a a kind of a tissue bank genomics program for breast cancer research in western Pennsylvania in affiliation with USUS and their breast cancer program.   (5:38 - 9:00) Then started a company called Inovio that was based on tech that I had helped pioneer involving use of post-electrical fields. That money was coming out of Norway, and we had just finished the incorporation of the American branch of Inovio when the planes hit the towers, and the investors pulled. Jill and I were left high and dry, and I reached out to a colleague at the Department of Business and Economic Development in the state of Maryland, who basically opened a door for a young federal contracting company that was really a satellite of, I didn't know it at the time, one of the two mercenary armies that were maintained at the time within the United States.   That was called DynCorp, the other one, of course, being Blackwater. And this is all in the context of the wars, and it occurred shortly after the anthrax attacks, which we were also right in the center of, living in Rockville, Maryland at the time. So, DynCorp, I joined as the associate clinical director, as I recall, and they had just acquired, it's called, the systems contract for all biodefense products for the Department of Defense.   So, suddenly, I went from being a discovery academic researcher, entrepreneur, doing startups and building labs and doing basic research and teaching, to just being thrown into the world of advanced development, which is to say, clinical research, regulatory affairs, program management, project management, business development, all of that world in the context of really an operation that was supporting USAMRID, which is the U.S. military biodefense base up in Frederick, Maryland. At one point, I was actually vetted to become chief science officer of USAMRID. Lost that out to a former VyCal employee who didn't last very long.   And I continued collaborating with people at USAMRID. That's where I did the Zika work with repurposing drugs. I've done a lot of cutting-edge stuff in drug repurposing.   I've done cutting-edge stuff in immunology, like intracellular cytokine staining technology development. I'm relatively proficient, or was at one time, in flow cytometry. But, in particular, at DynCorp, I really plunged into the whole world of government contracting, big government contracting, biodefense, have experience in literally all of the biodefense vaccines out there.   (9:01 - 10:36) So, the whole narrative that I don't have any background in vaccinology is absurd, for anybody that actually reads the CV. And have served as a study section member, and in many cases, study section chairperson, for both DoD and NIH NIAID contracts, largely in this space of biodefense. So, typically, I used to do SBIR review, but up until I started speaking out about COVID, it was more in the range of $80-$150 million contracts.   I have a lifetime capture of about $7 billion in federal funding for my clients. I'm formally trained by a Beltway Bandit company, TASC. It's been absorbed in federal business development.   I've worked for Aris Global TV Vaccine Foundation and PATH, PATH, which are both Gates-funded entities. So, again, the narrative that I don't know anything about vaccines, except for I've worked for all these vaccine companies. I was clinical director of influenza vaccines at Solvay before it got sold to Abbott.   (10:37 - 12:44) I was basically responsible for about $250 million in federal contract funds for the development of a cell-based influenza vaccine. So, a lot of that kind of work but I also did a fellowship in global clinical research at Harvard, a two-year fellowship. I've done hundreds of clinical trials, phase one through phase three, worked for a regulatory sweatshop in Rockville, filing INDs and meeting with the FDA and also with a clinical research organization, actually a few of them, that focus particularly on vaccines.   So, this is doing clinical trials. You can't be a principal investigator in clinical trials without taking a lot of bioethics training. They require it.   I was also trained in bioethics formally, both within the DoD world and at University of Maryland. So, I have a really strong background in bioethics. I was one of the principal whistleblowers about the Jesse Gelsinger case involving the adenovirus vector gene therapy death at University of Penn, associated with Jim Wilson, and kind of destroyed my academic career by doing that.   That's part of why I ended up doing Inovio and then moving into the DoD and spearheaded a bunch of work in Zika and also was working in support of DoD Defense Threat Reduction Agency. I've never worked for DARPA. That's another false meme.   But Defense Threat Reduction Agency, yes, in the ChemBio Defense Group. It was DTRA's Threat Mitigation Branch, separate branch. There is a major stock market crash coming that will rival the crash of 1929.   (12:45 - 14:41) But there is a way to not only protect your wealth, but profit in the coming crash. The stock market chart today looks exactly like the charts prior to October 1929. Banks are disastrously overleveraged and several major US banks have already failed.   And the CDIC, the Canadian Deposit Insurance Corporation, doesn't have nearly enough money to cover depositors. If you have money in the stock market, it is time to get out. Governments and corporations around the world are buying up precious metals in record amounts because they know the coming crash will make their other assets nearly worthless.   You can buy precious metals at wholesale prices, through New World Precious Metals, at premiums substantially below other Canadian brokerages. And you can even transfer savings in your RRSP tax-free. To get more information, use the link below this video to contact New World Precious Metals.   They will answer any questions you may have. You may also wish to contact Adrian Spitters, a personal financial consultant who successfully predicted the stock market crashes of 2000 and 2008. You will find Adrian's contact information below as well.   Finally, if you want more information on the to protect yourself, your family and your assets, see my most recent quarterly update with my team of financial experts at ironwiredaily.com. By clicking the link below to contact New World Precious Metals, you will also be helping to support our efforts to bring Canadians the truth, as we are an approved affiliate partner.